Skip to content

Glaukos GKOS Noncash Or Part Noncash Acquisition Contingent Consideration

Discontinued — last reported Q4 '25

Noncash Or Part Noncash Acquisition Contingent Consideration at other companies

Willis Towers Watson logo
Willis Towers WatsonWTW
$1.5M+100%
First Solar logo
First SolarFSLR
$6.5M-64.9%
Natera, Inc. logo
Natera, Inc.NTRA
$29.59M
Alkermes logo
AlkermesALKS
$5.56M-6.0%
Hyatt Hotels logo
Hyatt HotelsH
$0-100%
LPL Financial Holdings logo
LPL Financial HoldingsLPLA
$21.71M-1.2%

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept gkos:NoncashOrPartNoncashAcquisitionContingentConsideration.

The official record: Glaukos’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's noncash or part noncash acquisition contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's noncash or part noncash acquisition contingent consideration?
Glaukos (GKOS) reported noncash or part noncash acquisition contingent consideration of $1.93M in Q4 2025.
What does noncash or part noncash acquisition contingent consideration mean?
The value of future payments for acquisitions that are settled using non-cash instruments like stock or earn-outs.
How do you interpret noncash or part noncash acquisition contingent consideration?
An increase suggests the company is using performance-based incentives to mitigate acquisition risk, while a decrease may indicate fewer active earn-out agreements or completed milestone payments.
How does noncash or part noncash acquisition contingent consideration compare across companies?
Common in high-growth medical technology firms that use earn-outs to acquire smaller R&D-focused companies.